Mission Statement
The Coalition for Safe and Innovative Medicine
was founded to work toward creating a process for review and approval of safe and effective biosimilars versions of revolutionary biologic medicine that:
- Maintains the current high scientific standards to ensure patient safety
- Preserves incentives for innovation; and
- Lowers consumer costs
Congress should create a process for approval of new biosimilars that lowers consumer costs while ensuring patient safety and preserving incentives for innovation.
We support legislation currently being considered by Congress that would establish a safe and secure process for developing less expensive versions of complex biologic drugs.
We oppose a legislative approach that would lower standards of patient safety and undermine confidence in this life-altering field of new medicines by not ensuring these drugs are safety and efficacy.
Website Under Renovation
Thank you for visiting the Coalition for Safe & Innovative Medicine website.
We are currently undergoing renovation and will re-launch the website in mid-June 2009.
For more information, please contact:
Coalition for Safe and Innovative Medicine
PO Box 25250
Washington, DC 20027
202-298-7382
info@safeinnovativemedicine.com